← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2010Last known activity
May 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 8 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05283954Sponsor investigatorPhase 2/Phase 3May 1, 2022
- NCT05283954Lead sponsorPhase 2/Phase 3May 1, 2022
- NCT03676140Reponsible party - principal investigatorPhase 3Oct 31, 2018
- NCT03676140Lead sponsorPhase 3Oct 31, 2018
- NCT03664063Lead sponsorPhase 2Sep 30, 2018
- NCT03664063Reponsible party - principal investigatorPhase 2Sep 30, 2018
- NCT03490123Lead sponsorPhase 4Apr 1, 2018
- NCT03490123Reponsible party - principal investigatorPhase 4Apr 1, 2018
- NCT01785979Lead sponsorPhase 3Jan 1, 2016
- NCT01785979Reponsible party - principal investigatorPhase 3Jan 1, 2016
- NCT01785979Overall official - principal investigatorPhase 3Jan 1, 2016
- NCT02605720Lead sponsorPhase 3Sep 1, 2015
- NCT02605720Reponsible party - principal investigatorPhase 3Sep 1, 2015
- NCT01955252Lead sponsorPhase 3Mar 1, 2013
- NCT01955252Reponsible party - principal investigatorPhase 3Mar 1, 2013
Details
- Founded
- Londolovit, PG
- Last known activity
- May 1, 2022